Catalog Number MV0420-0006 |
Device Problems
Difficult to Remove (1528); Difficult or Delayed Separation (4044)
|
Patient Problems
No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/03/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
Date of event: unknown.The date received by manufacturer has been used for this field.Medical device lot #: the customer provided lot # 202016.This does not match the catalog number provided.Medical device expiration date: unknown.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.Device manufacture date: unknown.(b)(4).
|
|
Event Description
|
It was reported that smartsite 20mm vented vial access device was difficult to disconnect.The following information was provided by the initial reporter: i would like to inform you of an incident that occurred while using your device: vented vial access device 20mm.After striking a bottle of paclitaxel (hospira) with the spike mentioned above: cannot remove the liquid from the bottle.The operator tried several times to pull the piston out of his spike-screwed syringe, without success, even after testing to inject air into the vial with the syringe: it is not possible to use the well-adapted device on the bottle.A new spike must have been used to hit a new bottle.This incident has occurred several times with the specialty paclitaxel but also with other cytotoxic substances (notably zaltrap).
|
|
Manufacturer Narrative
|
The following fields were updated due to additional information: d.4.Medical device lot #: 202016.Is correct.D.4.Medical device expiration date: unknown.D10: device available for eval yes.D10: returned to manufacturer on: 2021-01-13.H.4.Device manufacture date: unknown.Investigation summary: one mv0420-0006 from lot 202016 was received without packaging for investigation.The device was received with an intact vial containing medication attached to it.A visual inspection of the sample received did not identify any product defects or manufacturing issues which could have contributed to the customer¿s experience; additionally it appeared that the vial access device had been correctly positioned.Functional testing was performed on the smartsite with a retained 50ml bd plastipak syringe; fluid was able to be withdrawn from the vial with no signs of occlusion or flow resistanc.The details of this feedback were shared with the legal manufacturer of the product, yukon medical llc, for investigation.A review of the production records for lot 202016 did not identify any in-process testing failures or quality deviations which may have resulted in a report of this nature.It was not possible to confirm the root cause of the customer¿s experience in this instance.Testing of the returned sample did not identify any product defects or quality deviations that could have contributed to the customer¿s experience.In this instance the connecting product was not returned for investigation, and therefore it could not be determined if this may have contributed to the customer's experience.A review of the customer feedback database indicates that this is a rare occurrence with a small number of similar reports against the mv0420-0006 set in the past 12 months.
|
|
Event Description
|
It was reported that smartsite 20mm vented vial access device was difficult to disconnect.The following information was provided by the initial reporter: i would like to inform you of an incident that occurred while using your device: vented vial access device 20mm.After striking a bottle of paclitaxel (hospira) with the spike mentioned above: cannot remove the liquid from the bottle.The operator tried several times to pull the piston out of his spike-screwed syringe, without success, even after testing to inject air into the vial with the syringe: it is not possible to use the well-adapted device on the bottle.A new spike must have been used to hit a new bottle.This incident has occurred several times with the specialty paclitaxel but also with other cytotoxic substances (notably zaltrap).
|
|
Search Alerts/Recalls
|